Mesorectal Fascia (MRF)
Definition
The MRF is a thin anatomic structure that envelops the rectum, mesorectal fat, mesorectal lymph nodes, and the vascular-lymphatic supply to the rectum.
Anatomy
- Below APR: Circumferential around the rectum
- Runs inferiorly over the surface of the levator ani muscles
- Terminates at the top of the puborectalis muscle
- Above APR: Posterolateral only; decreases as peritoneum progressively encircles the rectum ascending toward the STO
- The MRF and peritoneum merge laterally above the APR with no clear demarcation on imaging
MRF vs CRM (Critical Distinction)
See Circumferential Resection Margin for full discussion.
| Feature | MRF | CRM |
|---|---|---|
| Nature | Fixed anatomic structure | Variable surgical dissection plane |
| Depends on surgery type | No | Yes (varies with TME vs APR vs other) |
| Applies to peritonealized rectum | No (only nonperitonealized surface) | No |
| Use on preoperative MRI | Yes — report MRF involvement | No — should NOT be used as surrogate for MRF |
What Constitutes MRF Involvement
Structures Assessed for MRF Involvement
| Structure | Assessment Rule |
|---|---|
| Primary tumor (T3 only) | <1 mm from MRF at tumor base |
| EMVI | <1 mm from MRF |
| Tumor deposits | <1 mm from MRF |
| Spiculated heterogeneous lymph nodes | <1 mm from MRF |
| Smooth encapsulated lymph nodes (even if metastatic) | Do NOT report as MRF involvement |
| T1/T2 tumors | Not applicable (tumor within muscularis propria) |
Board Pearl
MRF involvement is assessed at the base of the tumor (the most likely point of muscularis propria transgression), NOT at the mucosal surface. The intact rectal wall adjacent to the tumor approximating the MRF does NOT constitute MRF involvement.
Key Assessment Steps
- Identify the point of breach of the muscularis propria (usually at tumor base)
- Confirm on multiplanar high-resolution T2WI
- Measure closest distance from most penetrating tumor component, EMVI, or spiculated nodule to MRF
- <1 mm = MRF involved
- Increasing cutoff from 1 mm to 5 mm reduced accuracy (higher false positives → unnecessary nCRT)
Special Situations
- Low rectal tumors extending into anal canal: Assess MRF only for the component above the puborectalis (MRF terminates there)
- Smooth encapsulated nodes near MRF: Even if potentially metastatic, do NOT report as MRF involvement (data shows no increased LR risk)
- Heterogeneous spiculated nodules: Cannot distinguish tumor deposits from replaced lymph nodes on imaging → treat both as MRF-threatening
MRI Performance
| Metric | Value |
|---|---|
| Negative predictive value (MRF clear) | 94-98.1% |
| Positive predictive value (MRF involved) | 86.5% |
| Safe measurement cutoff | 1 mm |
| Interobserver agreement | High (consistent across multiple trials) |
MRF Involvement Does NOT Change T Stage
- MRF involvement impacts need for nCRT and surgical planning
- It does NOT upstage T3 to T4b
- Peritoneal involvement (distinct from MRF) IS T4a